FDA Investigator: Nina Yang
- Nina Yang first started conducting FDA inspections in 2016, with the last inspection in 2021. Over that time, Nina Yang has conducted 74 inspections at 66 companies across 63 sites.
Get Nina Yang's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Novartis Pharmaceuticals, East Hanover | July 2019
Available Now - $199
Nina Yang
Human Drug Form 483
FDA 483 Novartis Pharmaceuticals, East Hanover | Jan 2017
Available Now - $199
Nina Yang
Human Drug Form 483
FDA 483 Insmed Incorporated, Bridgewater | 2021
Out-of-stock
Nina Yang
Human Drug Form 483
FDA 483 Merck & Company, Rahway | 2021
Out-of-stock
Nina Yang
Human Drug Form 483
Co-Investigators (19)
- Michael Serrano, FDA Investigator
- Kelly N. Kerr, FDA Investigator
- Xiaohan Cai, FDA Investigator
- Byungja E. Marciante, FDA Investigator
- Shirley S. Wen, FDA Investigator
- Cheryl A. Grandinetti, FDA Investigator
- Nancy M. Espinal, FDA Investigator
- Peter R. Lenahan, FDA Investigator
- Lauren C. Iacono-Connors, FDA Investigator
- Jean M. Mulinde, FDA Investigator
- Bei Yu, FDA Investigator
- Anastasia I. Offordile, FDA Investigator
- Barbara J. Maulfair, FDA Investigator
- Nancy F. Scheraga, FDA Investigator
- Melissa T. Roy, FDA Investigator
- Cary Greene, FDA Investigator
- Sherri J. Liu, FDA Investigator
- Lawrence R. Johnson, FDA Investigator
- Melissa B. Libby, FDA Investigator